Semaglutide is a GLP-1 receptor agonist it mimics a gut hormone that signals fullness, slows stomach emptying, and helps regulate blood sugar
doi: 10.1007/s00125-006-0237-0 139 BoeyDLinSEnriquezRFLeeNJSlackKCouzensMet al
Wegovy : Suitable for patients with a body mass index (BMI) of 30, or 27 with weight-related comorbidities
For Zepbound (weight management indication), doses increase from 2.5 mg to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg at 4-week intervals as tolerated
Advantages include a smaller injection volume, which some people prefer
Two to three pounds per week is common in the first few months, especially at higher starting weights